Observe Medical ASA announced a private placement of 55,000,000 common shares at a price of NOK 0.4 per share for the gross proceeds of NOK 22,000,000 on June 24, 2024. The transaction was raised in two tranches of 38,137,038 and 16,862,962 shares in each tranche. The transaction included participation from Terje Bakken, Line Tønnesen, Kathrine G. Andreassen, Eskild Endrerud total NOK 1,100,000, Jørgen Mann (CEO), Rune Nystad(CDO), Johan Fagerli (CFO) - shares for in total NOK 650,000.

Ingerø Reiten Investment Company AS has been allocated shares for NOK 2,250,000, and ELI AS has been allocated shares for NOK 1,200,000.